About Palleon Pharmaceuticals

Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.The company's biotechnology platform integrates technologies and insights from scientific leaders all over the world in the fields of glycoscience and human immunology to create a novel approach to treating cancer by targeting multiple immune cell types, providing physicians with a wider range of rational combination therapies to treat cancer and tackle resistanc

Repeat Founder
Company Highlights
Year Founded

2016

icon-altEmployees

31

Location (HQ)

USA

Since Last Funding

3 years 11 months

Monthly Website Visitors

1.4K

icon-altTotal Investment Amt

$100M

Last Funding Round

Series B

icon-altMoM Headcount Growth

-11.4%

icon-altYoY Headcount Growth

-31.04%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical

Health Care

Biotechnology

Biotechnology Research